Avidity Biosciences Inc
RNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$216.56M
Close$
$-10.57
182.5% downside
Current Fair Value
182.5% downsideOvervalued by 182.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $216.56 Million |
|---|---|
| Enterprise Value | $-39,267,560.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.48 |
| Beta | 0.42 |
| Outstanding Shares | 17,105,643 |
Return
| Return on Equity | -250.10% |
|---|---|
| Return on Assets | -200.26% |
| Return on Invested Capital | -222.14% |
Valuation & Multiples
| P/E Ratio | -3.35 |
|---|---|
| PEG | 3.91 |
| Price to Sales | 6.41 |
| Price to Book Ratio | 0.99 |
| Enterprise Value to Revenue | -1.07 |
| Enterprise Value to EBIT | 0.07 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.31 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-1.05
Average shareholder expectationRevenue Estimate
$2.00 M
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-1.18
Average shareholder expectationRevenue Estimate
$666,667
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 17.2875▲ 1319.72% |
|---|---|
| Total Calls | 66,000▼ 91.91% |
| Total Puts | 1,140,978▼ 65.80% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 86.76%▼ 788.22% |
|---|---|
| Total Invested | $198.55M▼ 91.01% |
| Investors Holding | 166▼ 201.00% |
ESG Score
No data